Inventor
Ana Maria Garcia Collazo
Inventor
Barcelona, ES
Overview
Patents· 4 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations31%
C07DHeterocyclic compounds31%
A61KPreparations for medical, dental or toiletry purposes23%
Y02ATechnologies for adaptation to climate change15%
PatentTitleYear
10,179,1262,4-thiazolidinedione derivatives in the treatment of central nervous system disorders20199,782,395'2,4-thiazolidinedione derivatives in the treatment of central nervous system disorders'20179,682,991'Tricyclic compounds for use as kinase inhibitors'20178,563,550'Imidazolothiadiazoles for use as protein kinase inhibitors'2013Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2013–2017Patents assigned to GARCIA COLLAZO ANA MARIA (2)· patent assignee history
2013Patents assigned to CT NAC INVESTIGACIONES ONCOLOGICAS CNIO (1)· patent assignee history
2013–2017Based in Madrid, ES· patent location history
2017–2019Patents assigned to MINORYX THERAPEUTICS S L (2)· patent assignee history
2017Patents assigned to BLANCO APARICIO CARMEN (1)· patent assignee history
2017Patents assigned to FUNDACIÓN CENTRO NAC DE INVESTIG ONCOLOGICAS CARLOS III (1)· patent assignee history
2017–2019Based in Barcelona, ES· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| GARCIA COLLAZO ANA MARIAself | 2 | 2013–2017 |
| MINORYX THERAPEUTICS S L | 2 | 2017–2019 |
| BLANCO APARICIO CARMEN | 1 | 2017 |
| CT NAC INVESTIGACIONES ONCOLOGICAS CNIO | 1 | 2013 |
| FUNDACIÓN CENTRO NAC DE INVESTIG ONCOLOGICAS CARLOS III | 1 | 2017 |
Locations
| Location | Patents | Span |
|---|---|---|
| Barcelona, ES | 2 | 2017–2019 |
| Madrid, ES | 2 | 2013–2017 |